BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19127072)

  • 1. Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study.
    Lehtimäki L; Petäys T; Haahtela T
    Int Arch Allergy Immunol; 2009; 149(2):150-3. PubMed ID: 19127072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis.
    Razi C; Bakirtas A; Harmanci K; Turktas I; Erbas D
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):767-74. PubMed ID: 17201236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
    Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
    Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
    van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
    Patel P; Philip G; Yang W; Call R; Horak F; LaForce C; Gilles L; Garrett GC; Dass SB; Knorr BA; Reiss TF
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):551-7. PubMed ID: 16400895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.
    Yanase DJ; David-Bajar K
    J Am Acad Dermatol; 2001 Jan; 44(1):89-93. PubMed ID: 11148482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?
    Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE
    Pediatr Allergy Immunol; 2006 Jun; 17(4):259-68. PubMed ID: 16771779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies.
    Chervinsky P; Philip G; Malice MP; Bardelas J; Nayak A; Marchal JL; van Adelsberg J; Bousquet J; Tozzi CA; Reiss TF
    Ann Allergy Asthma Immunol; 2004 Mar; 92(3):367-73. PubMed ID: 15049402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents.
    Harel Z; Riggs S; Vaz R; Flanagan P; Harel D
    J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):183-6. PubMed ID: 15125904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
    Mucha SM; deTineo M; Naclerio RM; Baroody FM
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast in general pediatric practices.
    Ngamphaiboon J
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
    Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
    Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U; Dass SB
    Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
    Kurowski M; Kuna P; Górski P
    Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise.
    Rundell KW; Spiering BA; Baumann JM; Evans TM
    Br J Sports Med; 2005 Apr; 39(4):232-6. PubMed ID: 15793094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.
    Veien NK; Busch-Sørensen M; Stausbøl-Grøn B
    J Am Acad Dermatol; 2005 Jul; 53(1):147-9. PubMed ID: 15965438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis.
    Meltzer EO; Philip G; Weinstein SF; LaForce CF; Malice MP; Dass SB; Santanello NC; Reiss TF
    Am J Rhinol; 2005; 19(6):591-8. PubMed ID: 16402647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind placebo-controlled trial of a leukotriene receptor antagonist in chronic pancreatitis in humans.
    Cartmell MT; O'Reilly DA; Porter C; Kingsnorth AN
    J Hepatobiliary Pancreat Surg; 2004; 11(4):255-9. PubMed ID: 15368110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.
    Ciprandi G; Tosca MA; Milanese M; Schenone G; Ricca V
    Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):67-70, 72. PubMed ID: 15061398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.